Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Antibiotic Selection

Antibiotic Selection

Antimicrobial Effectiveness

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...

Production of Antibiotics

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Insights into the methodology of acetyl-CoA carboxylase inhibition.

Methods in enzymology·2024

Same author

Kinetic characterization of the C-terminal domain of Malonyl-CoA reductase.

Biochimica et biophysica acta. Proteins and proteomics·2024

Same author

Kinetic characterization of the N-terminal domain of Malonyl-CoA reductase.

Biochimica et biophysica acta. Proteins and proteomics·2023

Same author

Mechanism of biotin carboxylase inhibition by ethyl 4-[[2-chloro-5-(phenylcarbamoyl)phenyl]sulphonylamino]benzoate.

Journal of enzyme inhibition and medicinal chemistry·2021

Same author

Pyrrolocin C and equisetin inhibit bacterial acetyl-CoA carboxylase.

PloS one·2020

Same author

Optimization and Mechanistic Characterization of Pyridopyrimidine Inhibitors of Bacterial Biotin Carboxylase.

Journal of medicinal chemistry·2019

Search research articles

Related Experiment Video

Updated: Jun 22, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Smaller is better for antibiotic discovery.

Grover L Waldrop¹

¹Division of Biochemistry and Molecular Biology, Louisiana State University, Baton Rouge, Louisiana 70803, USA. gwaldro@lsu.edu

ACS Chemical Biology

|June 23, 2009

Summary

Researchers developed new antibacterial compounds by targeting biotin carboxylase, a key enzyme. This study highlights fragment-based drug discovery as a promising strategy for novel antibiotic development.

Area of Science:

Biochemistry
Medicinal Chemistry
Microbiology

Background:

Biotin carboxylase (BC) is essential for bacterial survival.
Developing novel antibiotics is crucial due to rising antimicrobial resistance.
Fragment-based drug discovery (FBDD) offers an efficient approach to identify drug leads.

Discussion:

This study employed FBDD and virtual screening to identify inhibitors of bacterial biotin carboxylase.
The identified inhibitors demonstrated significant antibacterial activity.
Biotin carboxylase is validated as a viable target for antibiotic development.

Key Insights:

Successful application of FBDD for discovering antibacterial agents targeting BC.
Identification of novel chemical scaffolds with potential for antibiotic development.

More Related Videos

Stress-induced Antibiotic Susceptibility Testing on a Chip

Stress-induced Antibiotic Susceptibility Testing on a Chip

Published on: January 8, 2014

Visual and Microscopic Evaluation of Streptomyces Developmental Mutants

Visual and Microscopic Evaluation of Streptomyces Developmental Mutants

Published on: September 12, 2018

Related Experiment Videos

Last Updated: Jun 22, 2026

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Stress-induced Antibiotic Susceptibility Testing on a Chip

Stress-induced Antibiotic Susceptibility Testing on a Chip

Published on: January 8, 2014

Visual and Microscopic Evaluation of Streptomyces Developmental Mutants

Visual and Microscopic Evaluation of Streptomyces Developmental Mutants

Published on: September 12, 2018

Demonstration of BC inhibition as an effective antibacterial strategy.

Outlook:

Further optimization of identified inhibitors could lead to clinical drug candidates.
The presented FBDD framework can be applied to discover inhibitors for other essential bacterial targets.
This research contributes to the pipeline of new antibiotics to combat resistant infections.